Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | January 04, 2024 05:31pm

Gainers

  • Dermata Therapeutics (NASDAQ:DRMA) stock increased by 113.1% to $1.3 during Thursday's after-market session. The market value of their outstanding shares is at $4.6 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 19.17% to $0.36. The market value of their outstanding shares is at $3.1 million.
  • Exagen (NASDAQ:XGN) shares increased by 15.33% to $2.18. The market value of their outstanding shares is at $37.1 million.
  • Nemaura Medical (NASDAQ:NMRD) shares increased by 12.53% to $0.12. The market value of their outstanding shares is at $3.4 million.
  • Inspire Veterinary (NASDAQ:IVP) shares increased by 9.85% to $0.38. The market value of their outstanding shares is at $3.3 million.
  • MyMD Pharmaceuticals (NASDAQ:MYMD) stock increased by 9.52% to $0.23. The market value of their outstanding shares is at $11.7 million.

Losers

  • Applied Therapeutics (NASDAQ:APLT) stock declined by 36.9% to $2.39 during Thursday's after-market session. The market value of their outstanding shares is at $184.5 million.
  • Voyager Therapeutics (NASDAQ:VYGR) stock declined by 10.07% to $9.74. The company's market cap stands at $428.5 million.
  • Avenue Therapeutics (NASDAQ:ATXI) stock decreased by 9.59% to $0.31. The market value of their outstanding shares is at $4.1 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares decreased by 7.72% to $0.12. The company's market cap stands at $28.2 million.
  • Cognition Therapeutics (NASDAQ:CGTX) stock decreased by 6.99% to $1.85. The market value of their outstanding shares is at $59.4 million.
  • Allogene Therapeutics (NASDAQ:ALLO) stock decreased by 6.49% to $3.17. The market value of their outstanding shares is at $533.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLO APLT ATXI CGTX DRMA INBS IVP MYMD NMRD TCRT VYGR XGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist